Data on patients with advanced melanoma who are naive to anti-PD-1 therapy is the subject of a poster presentation and will be highlighted in a poster discussion session at the 2018 American Society for Clinical Oncology
(ASCO) Annual Meeting, being held June 1-5, 2018 in Chicago, IL.
"This study is part of the growing body of evidence showing that patients who are obese generally fare worse with cancer - in this case, younger women with breast cancer," said Clifford Hudis, president of the American Society for Clinical Oncology
Tumors began growing after 14.2 months in 21 people getting the vaccine, CDX-110, according to one study presented at a meeting of the American Society for Clinical Oncology
The survival time rose from 20.4 months to 25.5 months, a meeting of the American Society for Clinical Oncology
in Chicago heard.